Company Financials

AstraZeneca Financials

Pound sterling

business AstraZeneca Company Profile

Main Stock Listing

LSE: AZN

Market Capitalization £161.61 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 28.13
Forward PE 14.18
Price to Sales TTM £2.94
Price to Book MRQ £386.68
Enterprise to Revenue 3.33
Enterprise to EBITDA 10.03

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 14.14%
Operating Margin 27.94%
Return on Assets TTM 8.16%
Return on Equity TTM 19.79%

Income Statement

Revenue TTM £40,271,015,998
Revenue per Share TTM £35.47
Quarterly Revenue Growth 7.20%
Gross Profit TTM £33,200,771,134
EBITDA £16,065,000,000
Net Income to Common TTM £5,692,523,789
Diluted EPS TTM £3.64
Quarterly Earnings Growth YoY 33.80%

Balance Sheet

Total Cash MRQ £3,951,513,605
Total Cash per Share MRQ £3.48
Total Debt MRQ £
Total Debt to Equity MRQ 77.11
Current Ratio MRQ 0.90
Book Value per Share MRQ £26.48

Cash Flow

Operating Cash Flow TTM £9,586,174,589
Levered Free Cash Flow TTM £6,845,658,559

AZN Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 1,550,103,897
Float Shares 1,543,211,000
Avg 10 Volume 2,092,965
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 0.04%
% Held by Institutions 53.53%

Stock Price Summary

Beta 0.17
Fifty Two Week Low £9573.51
Fifty Two Week High £13388.00
Fifty Two Week Change -16.26%
Day 50 MA £10503.00
Day 200 MA £10923.48

Dividends and Splits

Forward Annual Dividend Rate £336.00
Forward Annual Dividend Yield 3.24%
Trailing Annual Dividend Rate £245.60
Trailing Annual Dividend Yield 2.37%
Payout Ratio 63.08%
Dividend Date
Ex Dividend Date 2025-02-20
Last Split Factor
Last Split Date